Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

View source ↗

Summary

A completed clinical trial describes the use and management of fidaxomicin in hospitalized patients with Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dificid (fidaxomicin)

Snippet

Sponsor: Astellas Pharma S.A.S. | Conditions: Clostridium Difficile Infection | Status: COMPLETED